<DOC>
	<DOC>NCT00973349</DOC>
	<brief_summary>This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 S-OIV (swine flu) vaccine in non-elderly and elderly adults.</brief_summary>
	<brief_title>Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>MF59 oil emulsion</mesh_term>
	<criteria>Adults 18 years of age and older in good health as determined by medical history, physical assessment and clinical judgement of the investigator and without influenza within the past 6 months. History of serious disease. History of serious reaction following administration of vaccine or hypersensitivity to vaccine components. Known or suspected impairment/alteration of immune function. Receipt or planned receipt of seasonal trivalent influenza vaccine within 1 week before or after each study vaccination. Sexually active women of childbearing potential must use acceptable birth control during the treatment phase of the study. For additional entry criteria, please refer to protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Swine Flu</keyword>
	<keyword>Flu</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Adults</keyword>
	<keyword>Elderly</keyword>
	<keyword>Non-Elderly</keyword>
	<keyword>Adjuvant</keyword>
</DOC>